Form 4 for IRD Opus Genetics, Inc.
Accepted 2024-01-22 00:00:00 ET · period of report 2024-01-18 · accession 0001140361-24-003192 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-22 | 2024-01-18 | IRD | Hoffmann Bernhard | SVP of Corp. Dev | A - Grant | $0.00 | +20.0K | 162.7K | +14% | $0 |
| D | 2024-01-22 | 2024-01-18 | IRD | Hoffmann Bernhard | SVP of Corp. Dev | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-18 | A | A | 20,000 | $0.00 | 162,697 | D | — | — | (F1) Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of January 18, 2024. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2024-01-18 | A | A | 30,000 | $0.00 | 30,000 | D | $2.77 · — to 2034-01-17 | 30,000 Common Stock | (F2) The option will vest with respect to 7,500 shares on January 18, 2025, with the balance vesting quarterly in twelve equal installments thereafter at the end of each quarter. |